Topics

Qynapse Secures FDA Clearance for Neurodegenerative Disease Imaging Software

07:14 EST 3 Feb 2020 | Diagnostic Imaging

Imaging software allows automated quantification of markers for early diagnosis and clinical monitoring.

Original Article: Qynapse Secures FDA Clearance for Neurodegenerative Disease Imaging Software

NEXT ARTICLE

More From BioPortfolio on "Qynapse Secures FDA Clearance for Neurodegenerative Disease Imaging Software"

Quick Search